Greenhouse Funds LLLP Has $84.86 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Greenhouse Funds LLLP lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 884,404 shares of the company's stock after purchasing an additional 91,935 shares during the quarter. HealthEquity comprises about 3.5% of Greenhouse Funds LLLP's investment portfolio, making the stock its 12th largest holding. Greenhouse Funds LLLP owned 1.02% of HealthEquity worth $84,859,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Wealthfront Advisers LLC acquired a new stake in HealthEquity in the 4th quarter valued at about $10,304,089,000. Vanguard Group Inc. lifted its stake in HealthEquity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock valued at $861,256,000 after purchasing an additional 99,624 shares during the last quarter. FMR LLC lifted its stake in HealthEquity by 2.4% during the fourth quarter. FMR LLC now owns 5,415,800 shares of the company's stock valued at $519,646,000 after purchasing an additional 125,684 shares during the last quarter. Geode Capital Management LLC boosted its holdings in HealthEquity by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock worth $200,522,000 after buying an additional 10,421 shares in the last quarter. Finally, Franklin Resources Inc. grew its position in HealthEquity by 0.7% in the third quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock worth $139,369,000 after buying an additional 11,659 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the sale, the director now owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. The trade was a 6.34 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,381 shares of company stock valued at $1,781,432 in the last three months. Insiders own 2.20% of the company's stock.

HealthEquity Stock Up 0.0 %

Shares of NASDAQ HQY traded up $0.04 during mid-day trading on Friday, reaching $85.87. The company had a trading volume of 559,483 shares, compared to its average volume of 771,464. The stock has a market capitalization of $7.43 billion, a PE ratio of 78.78, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock's 50 day moving average is $91.87 and its 200-day moving average is $96.42.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. The Goldman Sachs Group cut their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price objective for the stock from $120.00 to $115.00 in a report on Tuesday, March 25th. KeyCorp decreased their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Finally, Barrington Research restated an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a report on Friday, April 11th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, HealthEquity currently has a consensus rating of "Buy" and an average target price of $111.75.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.